S&P 500   4,288.41 (-1.13%)
DOW   33,697.57 (-0.91%)
QQQ   354.98 (-1.29%)
AAPL   172.73 (-1.90%)
MSFT   311.25 (-1.98%)
META   298.36 (-0.82%)
GOOGL   127.41 (-2.82%)
AMZN   127.02 (-3.24%)
TSLA   247.43 (+0.18%)
NVDA   422.20 (+0.00%)
NIO   8.54 (+2.28%)
BABA   86.24 (-1.12%)
AMD   96.33 (-1.08%)
T   14.97 (-0.60%)
F   12.51 (-0.56%)
MU   68.56 (-0.03%)
CGC   0.97 (+2.87%)
GE   110.24 (-1.32%)
DIS   80.31 (-0.86%)
AMC   8.27 (+1.60%)
PFE   32.68 (-0.91%)
PYPL   58.98 (+0.20%)
NFLX   383.51 (-0.34%)
S&P 500   4,288.41 (-1.13%)
DOW   33,697.57 (-0.91%)
QQQ   354.98 (-1.29%)
AAPL   172.73 (-1.90%)
MSFT   311.25 (-1.98%)
META   298.36 (-0.82%)
GOOGL   127.41 (-2.82%)
AMZN   127.02 (-3.24%)
TSLA   247.43 (+0.18%)
NVDA   422.20 (+0.00%)
NIO   8.54 (+2.28%)
BABA   86.24 (-1.12%)
AMD   96.33 (-1.08%)
T   14.97 (-0.60%)
F   12.51 (-0.56%)
MU   68.56 (-0.03%)
CGC   0.97 (+2.87%)
GE   110.24 (-1.32%)
DIS   80.31 (-0.86%)
AMC   8.27 (+1.60%)
PFE   32.68 (-0.91%)
PYPL   58.98 (+0.20%)
NFLX   383.51 (-0.34%)
S&P 500   4,288.41 (-1.13%)
DOW   33,697.57 (-0.91%)
QQQ   354.98 (-1.29%)
AAPL   172.73 (-1.90%)
MSFT   311.25 (-1.98%)
META   298.36 (-0.82%)
GOOGL   127.41 (-2.82%)
AMZN   127.02 (-3.24%)
TSLA   247.43 (+0.18%)
NVDA   422.20 (+0.00%)
NIO   8.54 (+2.28%)
BABA   86.24 (-1.12%)
AMD   96.33 (-1.08%)
T   14.97 (-0.60%)
F   12.51 (-0.56%)
MU   68.56 (-0.03%)
CGC   0.97 (+2.87%)
GE   110.24 (-1.32%)
DIS   80.31 (-0.86%)
AMC   8.27 (+1.60%)
PFE   32.68 (-0.91%)
PYPL   58.98 (+0.20%)
NFLX   383.51 (-0.34%)
S&P 500   4,288.41 (-1.13%)
DOW   33,697.57 (-0.91%)
QQQ   354.98 (-1.29%)
AAPL   172.73 (-1.90%)
MSFT   311.25 (-1.98%)
META   298.36 (-0.82%)
GOOGL   127.41 (-2.82%)
AMZN   127.02 (-3.24%)
TSLA   247.43 (+0.18%)
NVDA   422.20 (+0.00%)
NIO   8.54 (+2.28%)
BABA   86.24 (-1.12%)
AMD   96.33 (-1.08%)
T   14.97 (-0.60%)
F   12.51 (-0.56%)
MU   68.56 (-0.03%)
CGC   0.97 (+2.87%)
GE   110.24 (-1.32%)
DIS   80.31 (-0.86%)
AMC   8.27 (+1.60%)
PFE   32.68 (-0.91%)
PYPL   58.98 (+0.20%)
NFLX   383.51 (-0.34%)
NASDAQ:BDSI

BioDelivery Sciences International (BDSI) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$5.59
$5.60
50-Day Range
$5.54
$5.60
52-Week Range
$2.50
$5.62
Volume
2.09 million shs
Average Volume
3.34 million shs
Market Capitalization
$577.05 million
P/E Ratio
6.74
Dividend Yield
N/A
Price Target
N/A

BDSI stock logo

About BioDelivery Sciences International (NASDAQ:BDSI) Stock

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.


BDSI Stock News Headlines

Florida International University
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Science
Jim Cramer's Top Stock Picks: DF MNST BDSI
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
BioDelivery Sciences launches migraine therapy in U.S.
Should Value Investors Pick BioDelivery (BDSI) Stock Now?
BioDelivery Sciences International, Inc. (BDSI)
Tuesday 11/9 Insider Buying Report: BDSI, BALY
See More Headlines
Receive BDSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioDelivery Sciences International and its competitors with MarketBeat's FREE daily newsletter.

BDSI Company Calendar

Last Earnings
11/02/2021
Today
9/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NASDAQ:BDSI
CUSIP
09060J10
Employees
200
Year Founded
1997

Profitability

Net Income
$84.86 million
Pretax Margin
17.77%

Debt

Sales & Book Value

Annual Sales
$166.70 million
Cash Flow
$0.36 per share
Book Value
$1.90 per share

Miscellaneous

Free Float
92,927,000
Market Cap
$577.05 million
Optionable
Optionable
Beta
0.56

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Jeffrey Allen Bailey (Age 59)
    CEO & Director
    Comp: $599.96k
  • Mr. Scott M. Plesha (Age 57)
    Pres & Chief Commercial Officer
    Comp: $629.46k
  • Mr. James Vollins J.D.Mr. James Vollins J.D. (Age 53)
    Gen. Counsel, Chief Compliance Officer & Corp. Sec.
    Comp: $586.68k
  • Dr. Thomas B. Smith FAAFP (Age 61)
    M.D., Chief Medical Officer
    Comp: $570.06k
  • Mr. John GolubieskiMr. John Golubieski (Age 57)
    CFO & Chief Accounting Officer
  • Mr. Joseph M. Lockhart
    Sr. VP of Operations
  • Mr. Kevin Ostrander
    Sr. VP of Bus. Devel.
  • Dr. Bill McCarberg
    Member of Scientific Advisory Board and Member of Arius Scientific Advisory Board
  • Dr. Arthur G. Lipman PharmD
    Member of Scientific Advisory Board and Member of Arius Scientific Advisory Board
  • Dr. Jeff Katz
    Member of Scientific Advisory Board and Member of Arius Scientific Advisory Board













BDSI Stock - Frequently Asked Questions

How were BioDelivery Sciences International's earnings last quarter?

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) released its earnings results on Tuesday, November, 2nd. The specialty pharmaceutical company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.06 by $0.01. The specialty pharmaceutical company had revenue of $41.09 million for the quarter, compared to analysts' expectations of $42.05 million. BioDelivery Sciences International had a trailing twelve-month return on equity of 21.25% and a net margin of 50.90%. During the same quarter in the previous year, the business posted $0.09 EPS.

What other stocks do shareholders of BioDelivery Sciences International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioDelivery Sciences International investors own include TG Therapeutics (TGTX), Eldorado Gold (EGO), NVIDIA (NVDA), Inovio Pharmaceuticals (INO), Synergy Pharmaceuticals (SGYP), JD.com (JD), Baidu (BIDU), ACADIA Pharmaceuticals (ACAD), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

What is BioDelivery Sciences International's stock symbol?

BioDelivery Sciences International trades on the NASDAQ under the ticker symbol "BDSI."

What is BioDelivery Sciences International's stock price today?

One share of BDSI stock can currently be purchased for approximately $5.59.

How much money does BioDelivery Sciences International make?

BioDelivery Sciences International (NASDAQ:BDSI) has a market capitalization of $577.05 million and generates $166.70 million in revenue each year. The specialty pharmaceutical company earns $84.86 million in net income (profit) each year or $0.83 on an earnings per share basis.

How many employees does BioDelivery Sciences International have?

The company employs 200 workers across the globe.

How can I contact BioDelivery Sciences International?

BioDelivery Sciences International's mailing address is 4131 PARKLAKE AVENUE SUITE 225, RALEIGH NC, 27612. The official website for the company is www.bdsi.com. The specialty pharmaceutical company can be reached via phone at (919) 582-9050, via email at matthew@lifesciadvisors.com, or via fax at 919-582-9051.

This page (NASDAQ:BDSI) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -